Gepato-gastroenterologik tadqiqotlar jurnali 2026 №2

Maqola mavzusi

BOLALARDA PNEVMONIYANING KECHISH XUSUSIYATLARI (10-13)

Mualliflar

Ibragimova Yu.B.

Muassasa

Samarqand davlat tibbiyot universiteti

Annotatsiya

Pnevmoniya o‘pka parenximasining o‘tkir yuqumli kasalligi bo‘lib, uni viruslar, bakteriyalar va zamburug‘lar keltirib chiqaradi. Kasallikning oldini olishda immunizatsiya (emlash), yetarli va muvozanatli ovqatlanish hamda salbiy ekologik omillarni kamaytirish muhim ahamiyatga ega. Bakterial pnevmoniyalar antibiotiklar bilan samarali davolanishiga qaramay, pnevmoniya bilan kasallangan bolalarning atigi 30 foizi zarur bo‘lgan antibiotik terapiyasini oladi. Nafas olish tizimi kasalliklari orasida pnevmoniya butun dunyo bo‘yicha besh yoshgacha bo‘lgan bolalar o‘limining yetakchi sabablaridan biri hisoblanadi. Har yili ushbu kasallik tufayli taxminan 1,1 million nafar bola hayotdan ko‘z yumadi. Pnevmoniya global miqyosda keng tarqalgan bo‘lib, uni oddiy profilaktik choralar orqali oldini olish mumkin. Kasallik erta aniqlanib, bemor bolalar o‘z vaqtida shifoxonaga yotqizilib, to‘g‘ri parvarish qilinsa, oddiy va nisbatan arzon dori vositalari yordamida muvaffaqiyatli davolanadi.

Kalit so'zlar

Kalit so‘zlar: pnevmoniya, atipik pnevmoniya, bolalar, diagnostika, antibiotiklar.

Adabiyotlar

Список литературы/ Iqtiboslar / References 1.Таточенко В. К., Катосова Л. К., Федоров А. М. Этиологический спектр пневмоний у детей // Пульмонология. - 1997. – 2. – С. 29- 35. 2.Gendrel D. Pneumonies communautaires de l'enfant: etiologie et traitement // Arch. Pediatr. – 2002. - 9 (3). – С. 278 - 288. 3.Hendricson K. J. Viral pneumonia in children: Seminar in Pediatric infectious Diseases. - 1998. – 9. - С. 217 - 233. 4.Классификация клинических форм бронхолегочных заболеваний у детей // Вестник перинатол. и педиатрии. - 1996. -41. – 6. – С. 52 - 55. 5.Nix DE. Intrapulmonary concentrations of antimicrobial agents. Infect Dis Clin North Am.1998:12:631-646. 6.Carbon C. Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens. Clin Infect Dis. 1998:27:28- 32. 7.Nelson S, Summer WR. Innate immunity, cytokines, and pulmonary host defense. Infect Dis Clin North Am. 1998;12:555-567. 8.Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrob Agents Chemother. 1992:36:1176-1180. 9.Craig WA. Postantibiotic effects and the dosing of macrolides, azalides and streptogramins. In: Zinner SH, Young LS, Acar JF, Neu HC, eds. Expanding Indications for the New Macrolides, Azalides and Streptogramins. New York: Marcel Dekker Inc; 1997:27-38. 10.Forgie S, Marrie TJ. Healthcare-associated atypical pneumonia. Semin Respir Crit Care a. Med. Feb 2009;30(1):67-85. 11.Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. Mar 1 2007;44 Suppl 2:S27-72. 12.Honeybourne D, Baldwin DR. The site concentrations of antimicrobial agents in the lung. J Antimicrob Chemother. 1992;30:249-260. 13 Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother. 1992;36:1171 -1175 14 Пульмонология. Современный справочник для педиатров. – 2004. – C. 24-67. 13.World Health Organization (WHO).Revised WHO classification and treatment of pneumonia in children. Geneva, 2014. C 121-122. 14.Bradley J.S., Byington C.L., Shah S.S. et al.The management of community-acquired pneumonia in infants and children older than 3 months of age.Clinical Infectious Diseases, 2011; 53(7): e25–e76. 15.Mandell L.A., Wunderink R.G., Anzueto A. et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases, 2007; 44(Suppl 2): S27–S72. 16.PrincipiN.,EspositoS. Management of severe community-acquired pneumonia of childrenindevelopinganddevelopedcountries. Thorax, 2011; 66: 815–822. 17.MiyashitaN.,MatsushimaT.,OkaM. The role of atypical pathogens in community-acquired pneumonia. Journal of Infection and Chemotherapy, 2006; 12(3): 125–130. 18.Pneumonia in children: epidemiology, diagnosis and management. World Health Organization, Geneva. 2022. 142-145. 19.Nelson Textbook of Pediatrics Kliegman R.M. et al., 21-nashr. 48-49 Elsevier, 2020. 20.Harrison’s Principles of Internal Medicine. 20-nashr. McGraw-Hill Education, 2018. 21.Российское общество педиатров. Клинические рекомендации по диагностике и лечению пневмонии у детей, 2021.22.Principles and Practice of Pediatric Infectious Diseases. Long S.S., Prober C.G., Fischer M. Elsevier, 2018.122-123 22. Клинические рекомендации. Внебольничная пневмония у детей Российское общество педиатров, 2021.C 48-49